28Jun
[Audio] Episode 148 -- A Review of the Novartis and Alcon FCPA Enforcement Action
Even during this difficult time of the pandemic, economic uncertainty and social unrest, the Justice Department and the SEC have concluded a major FCPA enforcement action. Novartis and Alcon (which was a Novartis subsidiary at the time of the misconduct) agreed to pay a total of $345 million in criminal and civil penalties. Novartis spun off Alcon in 2019. Under the DOJ settlement, Novartis and Alcon each entered into a deferred prosecution agreement; Novartis agreed to pay a fine of $225...
By:
Michael Volkov
Source Url: https://www.jdsupra.com/legalnews/episode-148-a-review-of-the-novartis-40216/
Related
For construction employers anxious over how the Occupational Safety and Health Administration (OSHA)...
Read More >
In our previous alert, we described the sustainability reporting ecosystem shaping the disclosure pa...
Read More >
The FCPA Compliance Report is the longest running podcast in compliance, premiering on July 31, 2015...
Read More >
Climate change may make our summers hotter, but the ICEman still cometh. Since late 2017, Immigratio...
Read More >
In anticipation of the United Kingdom’s exit from the EU on December 31 (‘Brexit’), the Competiti...
Read More >
Addressing an issue of whether a letter exchange qualifies as a work for hire agreement under US cop...
Read More >